Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease

Hippocampus

Volumn 24, Issue 3, 2014, Pages 257-269

  Beauquis, Juan ^a   Vinuesa, Angeles ^a   Pomilio, Carlos ^a   Pavía, Patricio ^a   Galván, Verónica ^b   Saravia, Flavia ^a  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Cognitive deficit and anxiety; DCX; Glia; PDAPP mouse model of Alzheimer's disease; Pyramidal and granular neurons

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; PROTEIN C FOS; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; BRAIN NERVE CELL; CENTRAL NUCLEUS (AMYGDALA); COGNITIVE DEFECT; DENDRITIC CELL; DENTATE GYRUS; GLIA CELL; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; MOUSE; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL;

COGNITIVE DEFICIT AND ANXIETY; DCX; GLIA; PDAPP MOUSE MODEL OF ALZHEIMER'S DISEASE; PYRAMIDAL AND GRANULAR NEURONS;

ALZHEIMER DISEASE; AMYGDALA; AMYLOID; AMYLOID BETA-PEPTIDES; ANIMALS; ANXIETY; ASTROCYTES; ATROPHY; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; HUMANS; MEMORY DISORDERS; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEURONS; PEPTIDE FRAGMENTS; PLAQUE, AMYLOID; PROTO-ONCOGENE PROTEINS C-FOS; RECOMBINANT FUSION PROTEINS; SPATIAL BEHAVIOR; SYNAPTOPHYSIN;

EID: 84893969832     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.22219     Document Type: Article

References (53)

1. Abramoff MD, Magelhaes PJ, Ram SJ. 2004. Image Processing with ImageJ. Biophotonics International 11:36-42.
2. Albert MS. 2011. Changes in cognition. Neurobiol Aging 32 (Suppl 1):S58-S63.
3. Arendash GW, Garcia MF, Costa DA, Cracchiolo JR, Wefes IM, Potter H. 2004. Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta-amyloid deposition. Neuroreport 15:1751-1754.
4. Bansal R, Staib LH, Laine AF, Hao X, Xu D, Liu J, Weissman M, Peterson BS. 2012. Anatomical brain images alone can accurately diagnose chronic neuropsychiatric illnesses. PLoS One 7:e50698.
5. Barker GR, Warburton EC. 2011. When is the hippocampus involved in recognition memory? J Neurosci 31:10721-10731.
6. Beauquis J, Pavia P, Pomilio C, Vinuesa A, Podlutskaya N, Galvan V, Saravia F. 2013. Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease. Exp Neurol 239:28-37.
7. Beauquis J, Roig P, De Nicola AF, Saravia F. 2010. Short-term environmental enrichment enhances adult neurogenesis, vascular network and dendritic complexity in the hippocampus of type 1 diabetic mice. PLoS One 5:e13993.
8. Blennow K, de Leon MJ, Zetterberg H. 2006. Alzheimer's disease. Lancet 368:387-403.
9. Bohlen Und HO. 2009. Structure and function of dendritic spines within the hippocampus. Ann Anat 191:518-531.
10. Brun A. 2007. Identification and characterization of frontal lobe degeneration: Historical perspective on the development of FTD. Alzheimer Dis Assoc Disord 21:S3-S4.
11. Chvatal A, Anderova M, Hock M, Prajerova I, Neprasova H, Chvatal V, Kirchhoff F, Sykova E. 2007. Three-dimensional confocal morphometry reveals structural changes in astrocyte morphology in situ. J Neurosci Res 85:260-271.
12. Dubois B, Feldman HH, Jacova C, Cummings JL, DeKosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, et al. 2010. Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 9:1118-1127.
13. Ennaceur A, Neave N, Aggleton JP. 1996. Neurotoxic lesions of the perirhinal cortex do not mimic the behavioural effects of fornix transection in the rat. Behav Brain Res 80:9-25.
14. Galvan V, Gorostiza OF, Banwait S, Ataie M, Logvinova AV, Sitaraman S, Carlson E, Sagi SA, Chevallier N, Jin K, et al. 2006. Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc Natl Acad Sci USA 103:7130-7135.
15. Gemmell E, Bosomworth H, Allan L, Hall R, Khundakar A, Oakley AE, Deramecourt V, Polvikoski TM, O'Brien JT, Kalaria RN. 2012. Hippocampal neuronal atrophy and cognitive function in delayed poststroke and aging-related dementias. Stroke 43:808-814.
16. Gibb R, Kolb B. 1998. A method for vibratome sectioning of Golgi-Cox stained whole rat brain. J Neurosci Methods 79:1-4.
17. Gonzalez-Burgos I, Tapia-Arizmendi G, Feria-Velasco A. 1992. Golgi method without osmium tetroxide for the study of the central nervous system. Biotech Histochem 67:288-296.
18. Goodman T, Trouche S, Massou I, Verret L, Zerwas M, Roullet P, Rampon C. 2010. Young hippocampal neurons are critical for recent and remote spatial memory in adult mice. Neuroscience 171:769-778.
19. Heneka MT, Rodriguez JJ, Verkhratsky A. 2010. Neuroglia in neurodegeneration. Brain Res Rev 63:189-211.
20. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll RA, Mucke L. 1999. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci U S A 96:3228-3233.
21. Irizarry MC, Soriano F, McNamara M, Page KJ, Schenk D, Games D, Hyman BT. 1997. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci 17:7053-7059.
22. Jin K, Galvan V, Xie L, Mao XO, Gorostiza OF, Bredesen DE, Greenberg DA. 2004. Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw, Ind) mice. Proc Natl Acad Sci USA 101:13363-13367.
23. Kamphuis W, Mamber C, Moeton M, Kooijman L, Sluijs JA, Jansen AH, Verveer M, de Groot LR, Smith VD, Rangarajan S, et al. 2012. GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease. PLoS One 7:e42823.
24. Larson ME, Lesne SE. 2012. Soluble Abeta oligomer production and toxicity. J Neurochem 120(Suppl 1):125-139.
25. Leighty RE, Nilsson LN, Potter H, Costa DA, Low MA, Bales KR, Paul SM, Arendash GW. 2004. Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer's transgenic mouse lines differing in Abeta deposition. Behav Brain Res 153:107-121.
26. Lilja AM, Rojdner J, Mustafiz T, Thome CM, Storelli E, Gonzalez D, Unger-Lithner C, Greig NH, Nordberg A, Marutle A. 2013. Age-dependent neuroplasticity mechanisms in Alzheimer Tg2576 mice following modulation of brain amyloid-beta levels. PLoS One 8:e58752.
27. Marin-Burgin A, Schinder AF. 2012. Requirement of adult-born neurons for hippocampus-dependent learning. Behav Brain Res 227:391-399.
28. Moolman DL, Vitolo OV, Vonsattel JP, Shelanski ML. 2004. Dendrite and dendritic spine alterations in Alzheimer models. J Neurocytol 33:377-387.
29. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L. 2000. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. J Neurosci 20:4050-4058.
30. O'Donovan A, Slavich GM, Epel ES, Neylan TC. 2013. Exaggerated neurobiological sensitivity to threat as a mechanism linking anxiety with increased risk for diseases of aging. Neurosci Biobehav Rev 37:96-108.
31. Ohnishi T, Matsuda H, Tabira T, Asada T, Uno M. 2001. Changes in brain morphology in Alzheimer disease and normal aging: Is Alzheimer disease an exaggerated aging process? AJNR Am J Neuroradiol 22:1680-1685.
32. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A and others. 2007. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 55:697-711.
33. Palop JJ, Mucke L. 2009. Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol 66:435-440.
34. Parpura V, Verkhratsky A. 2012. Neuroglia at the crossroads of homeostasis, metabolism and signaling: Evolution of the concept. ASN Neuro
35. Penzes P, Vanleeuwen JE. 2011. Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease. Brain Res Rev 67:184-192.
36. Perez-Cruz C, Nolte MW, van Gaalen MM, Rustay NR, Termont A, Tanghe A, Kirchhoff F, Ebert U. 2011. Reduced spine density in specific regions of CA1 pyramidal neurons in two transgenic mouse models of Alzheimer's disease. J Neurosci 31:3926-3934.
37. Redwine JM, Kosofsky B, Jacobs RE, Games D, Reilly JF, Morrison JH, Young WG, Bloom FE. 2003. Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis. Proc Natl Acad Sci USA 100:1381-1386.
38. Revsin Y, Rekers NV, Louwe MC, Saravia FE, De Nicola AF, de Kloet ER, Oitzl MS. 2009. Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetes mice. Neuropsychopharmacology 34:747-758.
39. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L. 2007. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316:750-754.
40. Rodriguez JJ, Olabarria M, Chvatal A, Verkhratsky A. 2009. Astroglia in dementia and Alzheimer's disease. Cell Death Differ 16:378-385.
41. Schaeffer EL, Figueiro M, Gattaz WF. 2011. Insights into Alzheimer disease pathogenesis from studies in transgenic animal models. Clinics (Sao Paulo) 66 (Suppl 1):45-54.
42. Selkoe DJ. 2000. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann NY Acad Sci 924:17-25.
43. Senitz D, Reichenbach A, Smith TG, Jr. 1995. Surface complexity of human neocortical astrocytic cells: changes with development, aging, and dementia. J Hirnforsch 36:531-537.
44. Simon AM, Schiapparelli L, Salazar-Colocho P, Cuadrado-Tejedor M, Escribano L, Lopez dM, Del Rio J, Perez-Mediavilla A, Frechilla D. 2009. Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Abeta levels. Neurobiol Dis 33:369-378.
45. Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, Richardson A, Strong R, Galvan V. 2010. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One 5:e9979.
46. Steele ML, Robinson SR. 2012. Reactive astrocytes give neurons less support: Implications for Alzheimer's disease. Neurobiol Aging 33:423-413.
47. Taglialatela G, Hogan D, Zhang WR, Dineley KT. 2009. Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition. Behav Brain Res 200:95-99.
48. van de Nes JA, Nafe R, Schlote W. 2008. Non-tau based neuronal degeneration in Alzheimer's disease-An immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex. Brain Res 1213:152-165.
49. Verkhratsky A, Sofroniew MV, Messing A, Delanerolle NC, Rempe D, Rodriguez Arellano JJ, Nedergaard M. 2012. Neurological diseases as primary gliopathies: A reassessment of neurocentrism. ASN Neuro.
50. Vijayan VK, Geddes JW, Anderson KJ, Chang-Chui H, Ellis WG, Cotman CW. 1991. Astrocyte hypertrophy in the Alzheimer's disease hippocampal formation. Exp Neurol 112:72-78.
51. West MJ, Kawas CH, Martin LJ, Troncoso JC. 2000. The CA1 region of the human hippocampus is a hot spot in Alzheimer's disease. Ann NY Acad Sci 908:255-259.
52. Wilcock DM, Gordon MN, Morgan D. 2006. Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain. Nat Protoc 1:1591-1595.
53. Wright AL, Zinn R, Hohensinn B, Konen LM, Beynon SB, Tan RP, Clark IA, Abdipranoto A, Vissel B. 2013. Neuroinflammation and neuronal loss precede abeta plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease. PLoS One 8:e59586.